Fingerlakes1.com
Menu
Have a tip for the newsroom, press release, local event listing or digital content to share? Send it here. Support our mission by visiting patreon.com/fl1 and becoming a monthly subscriber.
Timothy L. Papsidero, M.D. has joined the medical staffs at Geneva General Hospital, 196 North Street, Geneva, and Soldiers & Sailors Memorial Hospital, 418 North Main Street, Penn Yan as a hospitalist.
He completed his residency in Family Medicine at Southern Colorado Family Medicine in Pueblo, Colorado and earned his medical degree at the University at Buffalo in Buffalo, NY.
Prior to coming to Finger Lakes Health, he was a hospitalist at Northwest Permanente in Portland, OR.
POLITICO
Get the Prescription Pulse newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by CVS Health
On Tap
as health officials worry about growing vaccine inequities. Novavax aims for 110m doses by July
after filing for U.S. authorization this summer. An at-home Covid test is here
after FDA authorized Quidel on Monday.
Boris Johnson at a COVID-19 media briefing in Downing Street. (Stefan Rousseau - WPA Pool/Getty Images)
LGBT+ Conservatives are being urged to use their weight in parliament to demand that Boris Johnson deliver on his long-awaited pledge to ban conversion therapy.
The traumatising practise of conversion therapy is still legal in the UK despite the government pledging to eradicate it over two and a half years ago.
As the prime minister continues to drag his heels, the Peter Tatchell Foundation is calling on queer Tories to stand up for their community and demand a ban.
“We believe that an appeal to Boris Johnson from LGBT+ Conservative MPs is likely to have the strongest influence. Their support will, hopefully, help encourage the prime minister to end the ceaseless delays and bring forward legislation,” Tatchell explained.
Published: Mar 02, 2021
New Board appointments strengthen Tenax with world-class expertise in cardiovascular drug development, commercial strategy, and business development
New Directors will provide significant guidance as Tenax is poised to advance its two leading drug candidates into late-stage clinical testing
Transformational step as Tenax strengthens its positioning as a leading specialty pharmaceutical company focused on cardio-pulmonary therapeutics
a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today announced the appointment of four new members to its board of directors: June Almenoff, MD, PhD, Michael Davidson, MD, Delcan Doogan, MD, and Stuart Rich, MD.